Act Two Investors’s Cognizant CTSH Stock Holding History

Act Two Investors’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,080	Closed	-$658K	–	39
2019 Q1	$658K	Hold	9,080	–	–	0.38%	33
2018 Q4	$576K	Buy	+9,080	New	+$632K	0.4%	31

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Act Two Investors's CTSH Position: Q2 2019 in Review

Act Two Investors sold out of Cognizant (CTSH) in Q2 2019, closing a stake of 9,080 shares — an estimated $658K sold.

Act Two Investors first reported a position in CTSH in Q4 2018 and held it in 2 quarters. The position peaked at $658K in Q1 2019. 930 funds tracked by Wall St. Rank hold CTSH as of Q2 2019.

Act Two Investors reported no remaining Cognizant position as of Q2 2019 after selling out during the quarter.
Act Two Investors sold 9,080 Cognizant shares in Q2 2019, an estimated $658K.
Act Two Investors first reported a position in Cognizant in Q4 2018 and held it in 2 quarters.
Act Two Investors's Cognizant position peaked at $658K in Q1 2019.
930 funds tracked by Wall St. Rank held Cognizant as of Q2 2019.

Based on Act Two Investors's 13F filing for Q2 2019, filed 14 Aug 2019.